In this study, we used urine samples from IgA nephropathy (IgAN) patients to evaluate the predictive capacity of the KIT Assay biomarkers to discriminate IgAN from healthy controls as well as predict progression of renal functional decline. The gene discussed is KIT; the disease is IgA glomerulonephritis.